nach oben

Erschienen in:

2020 | OriginalPaper | Buchkapitel

23. Kardiale Umfelddiagnostik bei Gefäßoperationen und Gefäßinterventionen

verfasst von : Julia Münch, Stefan Blankenberg

Erschienen in: Operative und interventionelle Gefäßmedizin

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

Dieses Kapitel stellt die perioperative kardiale Risikostratifizierung vor gefäßmedizinischen operativen und interventionellen Eingriffen basierend auf den Leitlinien der europäischen Gesellschaft für Kardiologie vom August 2014 dar (Kristensen et al. 2014).

Angiolillo DJ, Firstenberg MS, Price MJ, Tummala PE, Hutyra M, Welsby IJ et al (2012) Bridging anti-platelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial. JAMA 307:265–274PubMedPubMedCentralCrossRef

Antoniou GA, Chalmers N, Georgiadis GS, Lazarides MK, Antoniou SA, Serracino-Inglott F et al (2013) A meta-analysis of endovascular vs. surgical reconstruction of femoropopliteal arterial disease. J Vasc Surg 57:242–253PubMedCrossRef

Arulkumaran N, Corredor C, Hamilton MA, Ball J, Grounds RM, Rhodes A et al (2014) Cardiac complications associated with goal-directed therapy in high-risk surgical patients: a meta-analysis. Br J Anaesth 112:648–659PubMedCrossRef

Ashes C, Judelman S, Wijeysundera DN, Tait G, Mazer CD, Hare GM et al (2013) Selective b1-antagonism with bisoprolol is associated with fewer post-operative strokes than atenolol or metoprolol: a single-center cohort study of 44.092 consecutive patients. Anesthesiology 119:777–787PubMedCrossRef

Ashton CM, Petersen NJ, Wray NP, Kiefe CI, Dunn JK, Wu L et al (1993) The incidence of peri-operative myocardial infarction in men undergoing noncardiac surgery. Ann Intern Med 118:504–510PubMedCrossRef

Bauer SM, Cayne NS, Veith FJ (2010) New developments in the pre-operative evaluation and peri-operative management of coronary artery disease in patients undergoing vascular surgery. J Vasc Surg 51:242–251PubMedCrossRef

Biccard BM (2005) Relationship between the inability to climb two flights of stairs and outcome after major non-cardiac surgery: implications for the pre-operative assessment of functional capacity. Anaesthesia 60:588–593PubMedCrossRef

Biccard BM, Lurati Buse GA, Burkhart C, Cuthbertson BH, Filipovic M, Gibson SC et al (2012) The influence of clinical risk actors on pre-operative B-type natriuretic peptide risk stratification of vascular surgical patients. Anaesthesia 67:55–59PubMedCrossRef

Bijker JB, Persoon S, Peelen LM, Moons KG, Kalkman CJ, Kappelle LJ et al (2012) Intra-operative hypotension and peri-operative ischemic stroke after general surgery: a nested case-control study. Anesthesiology 116:658–664PubMedCrossRef

Bode RH, Lewis KP, Zarich SW, Pierce ET, Roberts M, Kowalchuk GJ et al (1996) Cardiac outcome after peripheral vascular surgery: comparison of general and regional anesthesia. Anesthesiology 84:3–13PubMedCrossRef

Brady AR, Gibbs JS, Greenhalgh RM, Powell JT, Sydes MR (2005) Peri-operative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. J Vasc Surg 41:602–609PubMedCrossRef

Brown LC, Powell JT, Thompson SG, Epstein DM, Sculpher MJ, Greenhalgh RM (2012) The UK EndoVascular Aneurysm Repair (EVAR) trials: randomised trials of EVAR vs. standard therapy. Health Technol Assess 16:1–218PubMedCrossRef

Burger W, Chemnitius JM, Kneissl GD, Rucker G (2005) Low-dose aspirin for secondary cardiovascular prevention: cardiovascular risks after its peri-operative withdrawal vs. bleeding risks with its continuation: review and meta-analysis. J Intern Med 257:399–414PubMedCrossRef

Calleja AM, Dommaraju S, Gaddam R, Cha S, Khandheria BK, Chaliki HP (2010) Cardiac risk in patients aged >75 years with asymptomatic, severe aortic stenosis undergoing noncardiac surgery. Am J Cardiol 105(8):1159–1163PubMedCrossRef

Canet J, Gallart L, Gomar C, Paluzie G, Vallès J, Castillo J et al (2010) Prediction of post-operative pulmonary complications in a population-based surgical cohort. Anesthesiology 113:1338–1350PubMedCrossRef

Cecconi M, Corredor C, Arulkumaran N, Abuella G, Ball J, Grounds RM et al (2013) Clinical review: goal-directed therapy-what is the evidence in surgical patients? The effect on different risk groups. Crit Care 17:209PubMedPubMedCentralCrossRef

Charlson ME, MacKenzie CR, Gold JP, Ales KL, Topkins M, Shires GT (1990) Intra-operative blood pressure. What patterns identify patients at risk for post-operative complications? Ann Surg 212:567–580PubMedPubMedCentralCrossRef

Chau EH, Lam D, Wong J, Mokhlesi B, Chung F (2012) Obesity hypoventilation syndrome: a review of epidemiology, pathophysiology, and peri-operative considerations. Anesthesiology 117:188–205PubMedCrossRef

Cowie B (2012) Focussed transthoracic echocardiography predicts peri-operative cardiovascular morbidity. J Cardiothorac Vasc Anesth 26:989–993PubMedCrossRef

Cutlip DE, Pinto DS (2012) Extracranial carotid disease revascularization. Circulation 126:2636–2644PubMedCrossRef

Dawood MM, Gutpa DK, Southern J, Walia A, Atkinson JB, Eagle KA (1996) Pathology of fatal peri-operative myocardial infarction: implications regarding pathophysiology and prevention. Int J Cardiol 57:37–44PubMedCrossRef

De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F et al (2012) New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper. J Am Coll Cardiol 59:1413–1425PubMedCrossRef

De Hert SG (2011) Cardioprotection by volatile anesthetics: what about noncardiac surgery? J Cardiothorac Vasc Anesth 25:899–901PubMedCrossRef

Dernellis J, Panaretou M (2006) Assessment of cardiac risk before non-cardiac surgery: nbrain natriuretic peptide in 1590 patients. Heart 92:1645–1650PubMedPubMedCentralCrossRef

Desai H, Aronow WS, Ahn C, Gandhi K, Amin H, Lai HM et al (2010) Incidence of peri-operative myocardial infarction and of 2-year mortality in 577 elderly patients undergoing noncardiac vascular surgery treated with and without statins. Arch Gerontol Geriatr 51:149–151PubMedCrossRef

Detsky AS, Abrams HB, Forbath N, Scott JG, Hilliard JR (1986) Cardiac assessment for patients undergoing noncardiac surgery. A multifactorial clinical risk index. Arch Intern Med 146:2131–2134PubMedCrossRef

Devereaux PJ, Goldman L, Cook DJ, Gilbert K, Leslie K, Guyatt GH (2005) Peri-operative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. CMAJ 173:627–634PubMedPubMedCentralCrossRef

Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC et al (2008) Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 371:1839–1847PubMedCrossRef

Devereaux PJ, Chan MT, Alonso-Coello P, Walsh M, Berwanger O, Villar JC et al (2012) Association between post-operative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA 307:2295–2304PubMedCrossRef

Devereaux PJ, Sessler DI, Leslie K, Kurz A, Mrkobrada M, Alonso-Coello P et al (2014a) Clonidine in patients undergoing noncardiac surgery. N Engl J Med 370:1504–1513PubMedCrossRef

Devereaux PJ, Mrkobrada M, Sessler DI, Leslie K, Alonso-Coello P, Kurz A et al (2014b) Aspirin in patients undergoing noncardiac surgery. N Engl J Med 370:1494–1503PubMedCrossRef

Díaz MQ, Borobia AM, Núnez MA, Virto AM, Fabra S, Casado MS et al (2013) Use of prothrombin complex concentrates for urgent reversal of dabigatran in the Emergency Department. Haematologica 98:e143–e144PubMedPubMedCentralCrossRef

Eagle KA, Rihal CS, Mickel MC, Holmes DR, Foster ED, Gersh BJ (1997) Cardiac risk of noncardiac surgery: influence of coronary disease and type of surgery in 3368 operations. Circulation 96:1882–1887PubMedCrossRef

Eerenberg ES, Kamphuisen PW, Sijpkens MK, Meijers JC, Buller HR, Levi M (2011) Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. Circulation 124:1573–1579PubMedCrossRef

Eisenberg MJ, London MJ, Leung JM, Browner WS, Hollenberg M, Tubau JF et al (1992) Monitoring for myocardial ischemia during noncardiac surgery. A technology assessment of transesophageal echocardiography and 12-lead electrocardiography. The Study of Peri-operative Ischemia Research Group. JAMA 268:210–216PubMedCrossRef

Erbel R, Aboyans V, Boileau C, Bossone E, Di Bartolomeo R, Eggebrecht H, Evangelista A, Falk V et al (2014) 2014 ESC guidelines on the diagnosis and treatment of aortic diseases. Eur Heart J 35:2873–2926. https://doi.org/10.1093/eurheartj/ehu281CrossRefPubMed

Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof EL, Fleischmann KE et al (2007) ACC/AHA 2007 guidelines on peri-operative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Peri-operative Cardiovascular Evaluation for Non-cardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol 50:e159–e241PubMedCrossRef

Ford MK, Beattie WS, Wijeysundera DN (2010) Systematic review: prediction of peri-operative cardiac complications and mortality by the revised cardiac risk index. Ann Intern Med 152:26–35PubMedCrossRef

Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA et al (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 30:2493–2537PubMedCrossRef

Goldman L, Caldera DL, Nussbaum SR, Southwick FS, Krogstad D, Murray B et al (1977) Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 297:845–850PubMedCrossRef

Guay J, Choi P, Suresh S, Albert N, Kopp S, Pace NL (2014) Neuraxial blockade for the prevention of post-operative mortality and major morbidity: an overview of Cochrane systematic reviews. Cochrane Database Syst Rev 1, CD010108

Guazzi M, Adams V, Conraads V, Halle M, Mezzani A, Vanhees L et al (2012) EACPR/AHA Joint Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Eur Heart J 33:2917–2927PubMedCrossRef

Gupta PK, Gupta H, Sundaram A, Kaushik M, Fang X, Miller WJ et al (2011) Development and validation of a risk calculator for prediction of cardiac risk after surgery. Circulation 124:381–387PubMedCrossRef

Halm EA, Browner WS, Tubau JF, Tateo IM, Mangano DT (1996) Echocardiography for assessing cardiac risk in patients having noncardiac surgery. Study of Peri-operative Ischemia Research Group. Ann Intern Med 125:433–441PubMedCrossRef

Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H et al (2011) ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 32:2999–3054PubMedCrossRef

Hammill BG, Curtis LH, Bennett-Guerrero E, O’Connor CM, Jollis JG, Schulman KA et al (2008) Impact of heart failure on patients undergoing major noncardiac surgery. Anesthesiology 108:559–567PubMedCrossRef

Haynes AB, Weiser TG, Berry WR, Lipsitz SR, Breizat AH, Dellinger EP et al (2009) Asurgical safety checklist to reduce morbidity and mortality in a global population. N Engl J Med 360:491–499PubMedCrossRef

Healey JS, Merchant R, Simpson C, Tang T, Beardsall M, Tung S et al (2012) Canadian Cardiovascular Society/Canadian Anesthesiologists’ Society/Canadian Heart Rhythm Society joint position statement on the peri-operative management of patients with implanted pacemakers, defibrillators, and neurostimulating devices. Can J Cardiol 28:141–151PubMedCrossRef

Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J et al (2013) European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. Europace 15:625–651PubMedCrossRef

Hindler K, Shaw AD, Samuels J, Fulton S, Collard CD, Riedel B (2006) Improved post-operative outcomes associated with pre-operative statin therapy. Anesthesiology 105:1260–1272;quiz 1289–1290PubMedCrossRef

Hofmann R, Kypta A, Steinwender C, Kerschner K, Grund M, Leisch F (2005) Coronary angiography in patients undergoing carotid artery stenting shows a high incidence of significant coronary artery disease. Heart 91:1438–1441PubMedPubMedCentralCrossRef

Howell SJ, Sear JW, Foëx P (2004) Hypertension, hypertensive heart disease and peri-operative cardiac risk. Br J Anaesth 92:570–583PubMedCrossRef

Huber KC, Evans MA, Bresnahan JF, Gibbons RJ, Holmes DR (1992) Outcome of noncardiac operations in patients with severe coronary-artery disease successfully treated pre-operatively with coronary angioplasty. Mayo Clin Proc 67:15–21PubMedCrossRef

Huber K, Connolly SJ, Kher A, Christory F, Dan GA, Hatala R et al (2013) Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation. Int J Clin Pract 67:516–526PubMedPubMedCentralCrossRef

Jacobi J, Bircher N, Krinsley J, Agus M, Braithwaite SS, Deutschman C et al (2012) Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med 40:3251–3276PubMedCrossRef

Jeger RV, Probst C, Arsenic R, Lippuner T, Pfisterer ME, Seeberger MD et al (2006) Long-term prognostic value of the pre-operative 12-lead electrocardiogram before major noncardiac surgery in coronary artery disease. Am Heart J 151:508–513PubMedCrossRef

Juul AB, Grp DT (2006) Effect of peri-operative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial. BMJ 332:1482–1485PubMedPubMedCentralCrossRef

Kaluza GL, Joseph J, Lee JR, Raizner ME, Raizner AE (2000) Catastrophic outcomes of non-cardiac surgery soon after coronary stenting. J Am Coll Cardiol 35:1288–1294PubMedCrossRef

Karthikeyan G, Moncur RA, Levine O, Heels-Ansdell D, Chan MT, Alonso-Coello P et al (2009) Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies. J Am Coll Cardiol 54:1599–1606PubMedCrossRef

Kazmers A, Cerqueira MD, Zierler RE (1988) Peri-operative and late outcome in patients with left ventricular ejection fraction of 35 % or less who require major vascular surgery. J Vasc Surg 8:307–315PubMedCrossRef

Kelm M, Schächinger V, Böhm M, Hoffmeister HM (2015) Kommentar zu den 2014-Leitlinien der Europäischen Gesellschaft für Kardiologie (ESC) und der Europäischen Gesellschaft für Anästhesiologie (ESA) zum Management kardiovaskulärer Erkrankungen bei nicht-kardialen chirurgischen Eingriffen. Kardiologe 9:283–288CrossRef

Kertai MD, Westerhout CM, Varga KS, Acsady G, Gal J (2008) Dihydropiridine calcium-channel blockers and peri-operative mortality in aortic aneurysm surgery. Br J Anaesth 101:458–465PubMedCrossRef

Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar A et al (2016) 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC Endorsed by the European Stroke Organisation (ESO). Eur Heart J. https://doi.org/10.1093/eurheartj/ehw210CrossRefPubMedPubMedCentral

Kristensen SD, Knuuti J, Saraste A, Anker S, Bøtker HE, De Hert S, Ford I, Gonzalez-Juanatey JR, Gorenek B, Heyndrickx GR, Hoeft A, Huber K, Iung B, Kjeldsen KP, Longroi D, Lüscher TF, Pierard L, Pocock S, Price S, Roffi M, Sirnes PA, Sousa-Uva M, Voudris V, Funck-Brentano C (2014) 2014 ESC/ESA guidelines on non-cardiac surgery: cardiovascular assessment and management. Eur Heart J 35:2383–2431. https://doi.org/10.1093/eurheartj/ehu282CrossRefPubMed

Landesberg G, Luria MH, Cotev S, Eidelman LA, Anner H, Mosseri M et al (1993) Importance of long-duration post-operative ST-segment depression in cardiac morbidity after vascular surgery. Lancet 341:715–719PubMedCrossRef

Landoni G, Greco T, Biondi-Zoccai G, Nigro Neto C, Febres D, Pintaudi M et al (2013) Anaesthetic drugs and survival: a Bayesian network meta-analysis of randomized trials in cardiac surgery. Br J Anaesth 111:886–896PubMedCrossRef

Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al (2006) Recommendations for chamber quantification. Eur J Echocardiogr 7:79–108PubMedCrossRef

Lau WC, Froehlich JB, Jewell ES, Montgomery DG, Eng KM, Shields TA et al (2013) Impact of adding aspirin to beta-blocker and statin in high-risk patients undergoing major vascular surgery. Ann Vasc Surg 27:537–545PubMedCrossRef

Le Manach Y, Godet G, Coriat P, Martinon C, Bertrand M, Fleron MH et al (2007) The impact of post-operative discontinuation or continuation of chronic statin therapy on cardiac outcome after major vascular surgery. Anesth Analg 104:1326–1333PubMedCrossRef

Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF et al (1999) Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 100:1043–1049PubMedCrossRef

Leung JM, Voskanian A, Bellows WH, Pastor D (1998) Automated electrocardiograph ST segment trending monitors: accuracy in detecting myocardial ischemia. Anesth Analg 87:4–10PubMed

Levy M, Heels-Ansdell D, Hiralal R, Bhandari M, Guyatt G, Yusuf S et al (2011) Prognostic value of troponin and creatine kinase muscle and brain isoenzyme measurement after noncardiac surgery: a systematic review and meta-analysis. Anesthesiology 114:796–806PubMedCrossRef

Lindenauer PK, Pekow P, Wang K, Gutierrez B, Benjamin EM (2004) Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery. JAMA 291:2092–2099PubMedCrossRef

Lindenauer PK, Pekow P, Wang KJ, Mamidi DK, Gutierrez B, Benjamin EM (2005) Peri-operative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 353:349–361PubMedCrossRef

Liu ZJ, Fu WG, Guo ZY, Shen LG, Shi ZY, Li JH (2012) Updated systematic review and meta-analysis of randomized clinical trials comparing carotid artery stenting and carotid endarterectomy in the treatment of carotid stenosis. Ann Vasc Surg 26:576–590PubMedCrossRef

London MJ, Hur K, Schwartz GG, Henderson WG (2013) Association of peri-operative beta-blockade with mortality and cardiovascular morbidity following major non-cardiac surgery. JAMA 309:1704–1713PubMedCrossRef

Lurati Buse GA, Schumacher P, Seeberger E, Studer W, Schuman RM, Fassl J et al (2012) Randomized comparison of sevoflurane vs propofol to reduce peri-operative myocardial ischemia in patients undergoing noncardiac surgery. Circulation 126:2696–2704PubMedCrossRef

Maisel AS, Bhalla V, Braunwald E (2006) Cardiac biomarkers: a contemporary status report. Nat Clin Pract Cardiovasc Med 3:24–34PubMedCrossRef

Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M et al (2013) 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 34:2159–2219PubMedCrossRef

Mangano DT, Layug EL, Wallace A, Tateo I (1996) Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Peri-operative Ischemia Research Group. N Engl J Med 335:1713–1720PubMedCrossRef

Marik PE, Preiser JC (2010) Toward understanding tight glycemic control in the ICU: a systematic review and metaanalysis. Chest 137:544–551PubMedCrossRef

Mauermann WJ, Shilling AM, Zuo Z (2006) A comparison of neuraxial block vs. general anesthesia for elective total hip replacement: a meta-analysis. Anesth Analg 103:1018–1025PubMedCrossRef

McFalls EO, Ward HB, Moritz TE, Goldman S, Krupski WC, Littooy F et al (2004) Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 351:2795–2804PubMedCrossRef

McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K et al (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 14:803–869PubMedCrossRef

McNally MM, Agle SC, Parker FM, Bogey WM, Powell CS, Stoner MC (2010) Preoperative statin therapy is associated with improved outcomes and resource utilization in patients undergoing aortic aneurysm repair. J Vasc Surg 51:1390–1396PubMedCrossRef

Memtsoudis SG, Sun X, Chiu YL, Stundner O, Liu SS, Banerjee S et al (2013) Peri-operative comparative effectiveness of anesthetic technique in orthopedic patients. Anesthesiology 118:1046–1058PubMedCrossRef

Mohr FW, Morice MC, Kappetein AP, Feldman TE, Ståhle E, Colombo A et al (2013) Coronary artery bypass graft surgery vs. percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 381:629–638PubMedCrossRef

Monaco M, Stassano P, Di Tommaso L, Pepino P, Giordano A, Pinna GB et al (2009) Systematic strategy of prophylactic coronary angiography improves long-term outcome after major vascular surgery in medium- to high-risk patients: a prospective, randomized study. J Am Coll Cardiol 54:989–996PubMedCrossRef

Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A et al (2013) 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 34:2949–3003PubMedCrossRef

Mookadam F, Carpenter SD, Thota VR, Cha S, Jiamsripong P, Alharthi MS et al (2011) Risk of adverse events after coronary artery bypass graft and subsequent noncardiac surgery. Future Cardiol 7:69–75PubMedCrossRef

Mor-Avi V, Lang RM, Badano LP, Belohlavek M, Cardim NM, Derumeaux G et al (2011) Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. Eur J Echocardiogr 12:167–205PubMedCrossRef

Morris CK, Ueshima K, Kawaguchi T, Hideg A, Froelicher VF (1991) The prognostic value of exercise capacity: a review of the literature. Am Heart J 122:1423–1431PubMedCrossRef

Ng JL, Chan MT, Gelb AW (2011) Peri-operative stroke in noncardiac, nonneurosurgical surgery. Anesthesiology 115:879–890PubMedCrossRef

Nuttall GA, Brown MJ, Stombaugh JW, Michon PB, Hathaway MF, Lindeen KC et al (2008) Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention. Anesthesiology 109:588–595PubMedCrossRef

Pannell LM, Reyes EM, Underwood SR (2013) Cardiac risk assessment before non-cardiac surgery. Eur Heart J Cardiovasc Imaging 14:316–322PubMedCrossRef

Paravastu SC, Jayarajasingam R, Cottam R, Palfreyman SJ, Michaels JA, Thomas SM (2014) Endovascular repair of abdominal aortic aneurysm. Cochrane Database Syst Rev 1, CD004178

Pengo V, Cucchini U, Denas G, Erba N, Guazzaloca G, LaRosa L et al (2009) Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery an inception cohort management study. Circulation 119:2920–2927PubMedCrossRef

Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M et al (2012) European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 33:1635–1701PubMedCrossRef

Polanczyk CA, Rohde LE, Goldman L, Cook EF, Thomas EJ, Marcantonio ER et al (2001) Right heart catheterization and cardiac complications in patients undergoing non-cardiac surgery: an observational study. JAMA 286:309–314PubMedCrossRef

Priebe HJ (2005) Peri-operative myocardial infarction: aetiology and prevention. Br J Anaesth 95:3–19PubMedCrossRef

Rajagopalan S, Croal BL, Reeve J, Bachoo P, Brittenden J (2011) N-terminal pro-B-type natriuretic peptide is an independent predictor of all-cause mortality and MACE after major vascular surgery in medium-term follow-up. Eur J Vasc Endovasc Surg 41:657–662PubMedCrossRef

Raux M, Godet G, Isnard R, Mergoni P, Goarin JP, Bertrand M et al (2006) Low negative predictive value of dobutamine stress echocardiography before abdominal aortic surgery. Br J Anaesth 97:770–776PubMedCrossRef

Redelmeier D, Scales D, Kopp A (2005) b-blockers for elective surgery in elderly patients: population based, retrospective cohort study. BMJ (Clinical Research ed) 331:932CrossRef

Rentsch M, Khandoga A, Angele M, Werner J (2015) Komplikationsmanagement in der Chirurgie. Springer, Berlin/HeidelbergCrossRef

Rigg JRA, Jamrozik K, Myles PS, Silbert BS, Peyton PJ, Parsons RW et al (2002) Epidural anaesthesia and analgesia and outcome of major surgery: a randomised trial. Lancet 359:1276–1282PubMedCrossRef

Rodgers A, Walker N, Schug S, McKee A, Kehlet H, van Zundert A et al (2000) Reduction of post-operative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials. BMJ 321:1493–1497PubMedPubMedCentralCrossRef

Rodseth RN, Padayachee L, Biccard BM (2008) A meta-analysis of the utility of pre-operative brain natriuretic peptide in predicting early and intermediate-term mortality and major adverse cardiac events in vascular surgical patients. Anaesthesia 63:1226–1233PubMedCrossRef

Rodseth RN, Biccard BM, Chu R, Lurati Buse GA, Thabane L, Bakhai A et al (2013) Post-operative B-type natriuretic peptide for prediction of major cardiac events in patients undergoing noncardiac surgery: systematic review and individual patient meta-analysis. Anesthesiology 119:270–283PubMedCrossRef

Rohde LE, Polanczyk CA, Goldman L, Cook EF, Lee RT, Lee TH (2001) Usefulness of transthoracic echocardiography as a tool for risk stratification of patients undergoing major noncardiac surgery. Am J Cardiol 87:505–509PubMedCrossRef

Sabaté S, Mases A, Guilera N, Canet J, Castillo J, Orrego C et al (2011) Incidence and predictors of major peri-operative adverse cardiac and cerebrovascular events in non-cardiac surgery. Br J Anaesth 107:879–890PubMedCrossRef

Schulmeyer C, Farías J, Rajdl E, de La Maza J, Labbé M (2010) Utility of transesophageal echocardiography during severe hypotension in non-cardiac surgery. Rev Bras Anestesiol 60:513–521PubMed

Sessler DI, Sigl JC, Kelley SD, Chamoun NG, Manberg PJ, Saager L et al (2012) Hospital stay and mortality are increased in patients having a „triple low“ of low blood pressure, low bispectral index, and low minimum alveolar concentration of volatile anesthesia. Anesthesiology 116:1195–1203PubMedCrossRef

Sharir T, Germano G, Kang X et al (2001) Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: risk stratification by the amount of stress-induced ischemia and the poststress ejection fraction. J Nucl Med 42:831–837PubMed

Sin DD, Wu LL, Man SFP (2005) The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 127:1952–1959PubMedCrossRef

Stather PW, Sidloff D, Dattani N, Choke E, Bown MJ, Sayers RD (2013) Systematic review and meta-analysis of the early and late outcomes of open and endovascular repair of abdominal aortic aneurysm. Br J Surg 100:863–872PubMedCrossRef

Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clément D, Collet JP et al (2011) ESC guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J 32:2851–2906PubMedCrossRef

Upshaw J, Kiernan MS (2013) Pre-operative cardiac risk assessment for noncardiac surgery in patients with heart failure. Curr Heart Fail Rep 10:147–156PubMedCrossRef

Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H et al (2012) Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 33:2451–2496PubMedCrossRef

Verzini F, DeRango P, Parlani G, Giordano G, Caso V, Cieri E et al (2011) Effects of statins on early and late results of carotid stenting. J Vasc Surg 53:71–79;discussion 79PubMedCrossRef

Wallace AW, Au S, Cason BA (2011) Peri-operative beta-blockade: atenolol is associated with reduced mortality when compared with metoprolol. Anesthesiology 114:824–836PubMedCrossRef

Walsh M, Devereaux PJ, Garg AX, Kurz A, Turan A, Rodseth RN et al (2013) Relationship between intra-operative mean arterial pressure and clinical outcomes after non-cardiac surgery: toward an empirical definition of hypotension. Anesthesiology 119:507–515PubMedCrossRef

Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Tetal O (2004) Plasmanatriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350:655–663PubMedCrossRef

Weber M, Luchner A, Seeberger M, Manfred S, Mueller C, Liebetrau C et al (2013) Incremental value of high-sensitive troponin T in addition to the revised cardiac index for peri-operative risk stratification in non-cardiac surgery. Eur Heart J 34:853–862PubMedCrossRef

Weiser TG, Regenbogen SE, Thompson KD, Haynes AB, Lipsitz SR, Berry WR et al (2008) An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet 372:139–144PubMedCrossRef

Wijns W, Kolh P, Danchin N, DiMario C, Falk V, Folliguet T et al (2010) Guidelines on myocardial revascularization. Eur Heart J 31:2501–2555PubMedCrossRef

Wiklund RA, Stein HD, Rosenbaum SH (2001) Activities of daily living and cardiovascular complications following elective, noncardiac surgery. Yale J Biol Med 74:75–87PubMedPubMedCentral

Wirthlin DJ, Cambria RP (1998) Surgery-specific considerations in the cardiac patient undergoing noncardiac surgery. Prog Cardiovasc Dis 40:453–468PubMedCrossRef

Wong EY, Lawrence HP, Wong DT (2007) The effects of prophylactic coronary revascularization or medical management on patient outcomes after noncardiac surgery: a meta-analysis. Can J Anaesth 54:705–717PubMedCrossRef

Wu CL, Rowlingson AJ, Herbert R, Richman JM, Andrews RAF, Fleisher LA (2006) Correlation of post-operative epidural analgesia on morbidity and mortality after colectomy in Medicare patients. J Clin Anesth 18:594–599PubMedCrossRef

Yang H, Raymer K, Butler R, Parlow J, Roberts R (2006) The effects of peri-operative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J 152:983–990PubMedCrossRef

Zangrillo A, Testa V, Aldrovandi V, Tuoro A, Casiraghi G, Cavenago F et al (2011) Volatile agents for cardiac protection in noncardiac surgery: a randomized controlled study. J Cardiothorac Vasc Anesth 25:902–907PubMedCrossRef

Zaugg M, Bestmann L, Wacker J, Lucchinetti E, Boltres A, Schulz C et al (2007) Adrenergic receptor genotype but not peri-operative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss Beta Blocker in Spinal Anesthesia (BBSA) study: a double-blinded, placebo-controlled, multicenter trial with 1-year follow-up. Anesthesiology 107:33–44PubMedCrossRef

Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M et al (2006) ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur Heart J 27:2099–2140PubMedCrossRef

Titel: Kardiale Umfelddiagnostik bei Gefäßoperationen und Gefäßinterventionen
verfasst von: Julia Münch
Stefan Blankenberg
Verlag: Springer Berlin Heidelberg
Buch: Operative und interventionelle Gefäßmedizin
Print ISBN: 978-3-662-53378-9

Electronic ISBN: 978-3-662-53380-2

Copyright-Jahr: 2020
DOI: https://doi.org/10.1007/978-3-662-53380-2_28

Neu im Fachgebiet Chirurgie

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Wie sieht der OP der Zukunft aus?

04.05.2024 DCK 2024 Kongressbericht

Der OP in der Zukunft wird mit weniger Personal auskommen – nicht, weil die Technik das medizinische Fachpersonal verdrängt, sondern weil der Personalmangel es nötig macht.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Recycling im OP – möglich, aber teuer

02.05.2024 DCK 2024 Kongressbericht

Auch wenn sich Krankenhäuser nachhaltig und grün geben – sie tragen aktuell erheblich zu den CO₂-Emissionen bei und produzieren jede Menge Müll. Ein Pilotprojekt aus Bonn zeigt, dass viele Op.-Abfälle wiederverwertet werden können.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Update Chirurgie